SEC Contract Filing

Filing Date: 2019-02-20

Document Content:
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>azrx_ex105.htm
<DESCRIPTION>WARRANT AMENDMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: right; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold">&#xA0; <font style="font-family: Times New Roman; font-size: 13px">Exhibit
10.5</font><br></font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">AZURRX
BIOPHARMA, INC.</font></div>
<div style="text-align: center; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="font-family: Times New Roman; font-size: 13px">760
Parkside Avenue, Suite 304 Brooklyn, New York 11226</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">February 14,
2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 48px; margin-right: 343px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">To the
Investor Signatories to The Note Purchase Agreement</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table; margin-left: 51px;">
<div style="display: table-row">
<div style="display: table-cell; width: 49px"><font style="font-family: Times New Roman; font-size: 13px">Re:&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="text-decoration: underline; font-family: Times New Roman; font-size: 13px">
Warrant Amendment</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 23px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Reference is hereby
made to those common stock purchase warrants set forth in
<font style="text-decoration: underline">Exhibit A</font> hereto
(each a &#x201C;<font style="font-style: italic">Warrant</font>,&#x201D; and together the
&#x201C;<font style="font-style: italic">Warrants</font>&#x201D;).
Capitalized terms used but not otherwise defined herein shall have
the meaning ascribed to such terms in each of the
Warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 23px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with, and as partial consideration for, the sale and
issuance of certain Senior Convertible Promissory Notes by AzurRx
BioPharma, Inc. (the &#x201C;<font style="font-style: italic">Company</font>&#x201D;) to certain investor
signatories to that certain Note Purchase Agreement, dated February
14, 2019 (&#x201C;<font style="font-style: italic">NPA</font>&#x201D;), the Company hereby agrees
to amend each Warrant to decrease the Exercise Price thereof to
$1.50 per share (the &#x201C;<font style="font-style: italic">Warrant Amendment</font>&#x201D;). This
agreement shall only serve to amend the Exercise Price of each of
the Warrants set forth on <font style="text-decoration: underline">Exhibit A</font> attached hereto, and
all other terms of the Warrants shall remain in full force and
effect.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 23px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
furtherance of the foregoing, the Company shall prepare, execute
and deliver to the holder of each Warrant a formal amendment to
each Warrant to effect the agreement of the Company set forth
herein, on or before ten (10) business days from the date
hereof.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Very
truly yours,</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">AZURRX
BIOPHARMA, INC.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">By:
<font style="text-decoration: underline">/s/ Johan M.
Spoor</font></font></div>
<div style="text-align: justify; margin-left: 48px; margin-rig